Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors

Archiv der Pharmazie
Yi WangShutao Ma

Abstract

A series of novel 4-bromo-1H-indazole derivatives as filamentous temperature-sensitive protein Z (FtsZ) inhibitors were designed, synthesized, and assayed for their in vitro antibacterial activity against various phenotypes of Gram-positive and Gram-negative bacteria and their cell division inhibitory activity. The results indicated that this series showed better antibacterial activity against Staphylococcus epidermidis and penicillin-susceptible Streptococcus pyogenes than the other tested strains. Among them, compounds 12 and 18 exhibited 256-fold and 256-fold more potent activity than 3-methoxybenzamide (3-MBA) against penicillin-resistant Staphylococcus aureus, and compound 18 showed 64-fold better activity than 3-MBA but 4-fold weaker activity than ciprofloxacin in the inhibition of S. aureus ATCC29213. Particularly, compound 9 presented the best activity (4 µg/mL) against S. pyogenes PS, being 32-fold, 32-fold, and 2-fold more active than 3-MBA, curcumin, and ciprofloxacin, respectively, but it was four times less active than oxacillin sodium. In addition, some synthesized compounds displayed moderate inhibition of cell division against S. aureus ATCC25923, Escherichia coli ATCC25922, and Pseudomonas aeruginosa ATCC27853,...Continue Reading

References

Jul 1, 1996·Journal of Bacteriology·S G AddinallJ Lutkenhaus
Jan 1, 1997·Annual Review of Biochemistry·J Lutkenhaus, S G Addinall
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Nov 18, 2003·Molecular Microbiology·Mariana G Pinho, Jeff Errington
Dec 11, 2003·British Journal of Anaesthesia·K J HardyB A Oppenheim
May 14, 2004·Annual Review of Biophysics and Biomolecular Structure·Jan LöweLinda A Amos
Feb 25, 2005·Bioorganic & Medicinal Chemistry·A Khalafi-NezhadB Hemmateenejad
Sep 22, 2005·The Journal of Biological Chemistry·Neil R StokesJeff Errington
Oct 6, 2005·Bioorganic & Medicinal Chemistry·Li-Jiau HuangSheng-Chu Kuo
Feb 16, 2008·Biochemistry·Prerna N DomadiaDebjani Dasgupta
Mar 8, 2008·Nature Reviews. Drug Discovery·Rowena L Lock, Elizabeth J Harry
Apr 19, 2008·Science·Masaki OsawaHarold P Erickson
Sep 3, 2008·European Journal of Medicinal Chemistry·Jorge RodríguezHugo Cerecetto
Sep 20, 2008·Science·David J HaydonLloyd G Czaplewski
Mar 12, 2009·Current Molecular Medicine·Ruud H Deurenberg, Ellen E Stobberingh
Aug 15, 2009·Nature Reviews. Microbiology·David W Adams, Jeff Errington
Mar 10, 2010·The Journal of Biological Chemistry·José M AndreuAntonio J Martín-Galiano
Dec 4, 2010·Journal of Medicinal Chemistry·Kunal KumarIwao Ojima
Dec 27, 2011·International Journal of Antimicrobial Agents·Ian M GouldGeorg Peters
Oct 23, 2012·Bioorganic & Medicinal Chemistry Letters·Ajit ParhiEdmond J LaVoie
Jan 15, 2013·European Journal of Medicinal Chemistry·Cody KelleyEdmond J Lavoie
Mar 14, 2013·Bioorganic & Medicinal Chemistry Letters·Yongzheng ZhangEdmond J LaVoie

❮ Previous
Next ❯

Citations

Jan 13, 2016·Journal of Medicinal Chemistry·Katherine Ann HurleyDouglas B Weibel
Jan 26, 2018·Journal of Receptor and Signal Transduction Research·Srilata BalluVijjulatha Manga
Oct 18, 2016·Acta Crystallographica. Section E, Crystallographic Communications·Özden Özel GüvenTuncer Hökelek
Jul 28, 2020·Pharmaceuticals·Artur AdamczakTomasz M Karpiński
Jul 4, 2019·ACS Infectious Diseases·Kennardy D KusumaElizabeth J Harry

❮ Previous
Next ❯

Related Concepts